Antiapoptotic effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutantin H9c2 rat cardiomyocytes

BMB Reports

Volumn 45, Issue 12, 2012, Pages 742-747

  Chung, Hee Kyoung ^a,c   Ko, Eun Mi ^b   Kim, Sung Woo ^a   Byun, Sung June ^a   Chung, Hak Jae ^a   Kwon, Moosik ^c   Lee, Hwi Cheul ^a   Yang, Byoung Chul ^a   Han, Deug Woo ^a   Park, Jin Ki ^a   Hong, Sung Gu ^a   Chang, Won Kyong ^a   Kim, Kyung Woon ^a  

^a National Institute of Animal Science   (South Korea)

^b National Academy of Agricultural Science   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Antiapoptotic activity; Heart failure; hG CSF (Phe140Asn)

Indexed keywords

CASPASE 3; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL LINE; CHO CELL; CRICETULUS; CYTOLOGY; DRUG EFFECT; GENETICS; GLYCOSYLATION; HAMSTER; HEART MUSCLE CELL; METABOLISM; MOLECULAR GENETICS; RAT; UPREGULATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; GLYCOSYLATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HYDROGEN PEROXIDE; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; POLY(ADP-RIBOSE) POLYMERASES; RATS; RECOMBINANT PROTEINS; UP-REGULATION;

RATTUS;

EID: 84872320897     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.12.095     Document Type: Article

References (33)

1. Takano, H., Qin, Y., Hasegawa, H., Ueda, K., Niitsuma, Y., Ohtsuka, M. and Komuro, I. (2006) Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J. Mol. Med. 84, 185-193.
2. Minatoguchi, S., Takemura, G., Chen, X. H., Wang, N., Uno, Y., Koda, M., Arai, M., Misao, Y., Lu, C., Suzuki, K., Goto, K., Komada, A., Takahashi, T., Kosai, K., Fujiwara, T. and Fujiwara, H. (2004) Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by post-infarction granulocyte colony-stimulating factor treatment. Circulation 109, 2572-2580.
3. Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A. and Anversa, P. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U.S.A. 98, 10344-10349.
4. Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsuura, K., Sano, M., Nishi, J., Iwanaga, K., Akazawa, H., Kunieda, T., Zhu, W., Hasegawa, H., Kunisada, K., Nagai, T., Nakaya, H., Yamauchi-Takihara, K. and Komuro, I. (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11, 305-311.
5. Martin-Christin, F. (2001) Granulocyte colony stimulating factors: how different are they? How to make a decision? Anticancer. Drugs. 12, 185-191.
6. Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J. and Tedgui, A. (1998) Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97, 1536-1539.
7. Hill, M. F. and Singal, P. K. (1996) Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am. J. Pathol. 148, 291-300.
8. Eguchi, M., Liu, Y., Shin, E. J. and Sweeney, G. (2008) Leptin protects H9c2 rat cardiomyocytes from H2O2-induced apoptosis. FEBS J. 275, 3136-3144.
9. Liu, J., Mao, W., Ding, B. and Liang, C. S. (2008) ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am. J. Physiol. Heart. Circ. Physiol. 295, H1956-1965.
10. Souza, L. M., Boone, T. C., Gabrilove, J., Lai, P. H., Zsebo, K. M., Murdock, D. C., Chazin, V. R., Bruszewski, J., Lu, H., Chen, K. K., Barendt, J., Platzer, E., Moore, M. A. S., Mertelsmann, R. and Welte, K. (1986) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232, 61-65.
11. Kubota, N., Orita, T., Hattori, K., Oh-eda, M., Ochi, N. and Yamazaki, T. (1990) Structural characterization of natural and recombinant human granulocyte colony-stimulating factors. J. Biochem. 107, 486-492.
12. Gervais, V., Zerial, A. and Oschkinat, H. (1997) NMR investigations of the role of the sugar moiety in glycosylated recombinant human granulocyte-colony-stimulating factor. Eur. J. Biochem. 247, 386-395.
13. Cumming, D. A. (1991) Glycosylation of recombinant protein therapeutics: control and functional implications. Glycobiology 1, 115-130.
14. Chung, H. K., Kim, S. W., Byun, S. J., Ko, E. M., Chung, H. J., Woo, J. S., Yoo, J. G., Lee, H. C., Yang, B. C., Kwon, M., Park, S. B., Park, J. K. and Kim, K. W. (2011) Enhanced biological effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant, on HL60 cells. BMB Rep. 44, 686-691.
15. Lu, H. S., Boone, T. C., Souza, L. M. and Lai, P. H. (1989) Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor. Arch. Biochem. Biophys. 268, 81-92.
16. Ishikawa, M., Iijima, H., Satake-Ishikawa, R., Tsumura, H., Iwamatsu, A., Kadoya, T., Shimada, Y., Fukamachi, H., Kobayashi, K., Matsuki, S. and Asano, K. (1992) The substitution of cysteine 17 of recombinant human G-CSF with ala-nine greatly enhanced its stability. Cell Struct. Funct. 17, 61-65.
17. Bishop, B., Koay, D. C., Sartorelli, A. C. and Regan, L. (2001) Reengineering granulocyte colony-stimulating factor for enhanced stability. J. Biol. Chem. 276, 33465-33470.
18. Tarentino, A. L., Gomez, C. M. and Plummer, T. H. Jr. (1985) Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. Biochemistry 24, 4665-4671.
19. Chu, F. K. (1986) Requirements of cleavage of high mannose oligosaccharides in glycoproteins by peptide N-glycosidase F. J. Biol. Chem. 261, 172-177.
20. Umemoto, J., Bhavanandan, V. P. and Davidson, E. A. (1977) Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae. J. Biol. Chem. 252, 8609-8614.
21. Wang, Z., Cui, M., Sun, L., Jia, Z., Bai, Y., Ma, K., Chen, F. and Zhou, C. (2007) Angiopoietin-1 protects H9c2 cells from H2O2-induced apoptosis through AKT signaling. Biochem. Biophys. Res. Commun. 359, 685-690.
22. Takano, H., Ueda, K., Hasegawa, H. and Komuro, I. (2007) G-CSF therapy for acute myocardial infarction. Trends. Pharmacol. Sci. 28, 512-517.
23. Kornfeld, R. and Kornfeld, S. (1985) Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54, 631-664.
24. Van den Steen, P., Rudd, P. M., Dwek, R. A. and Opdenakker, G. (1998) Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 33, 151-208.
25. Burda, P. and Aebi, M. (1999) The dolichol pathway of N-linked glycosylation. Biochim. Biophys. Acta. 1426, 239-257.
26. Munro, S. (2001) What can yeast tell us about N-linked glycosylation in the Golgi apparatus? FEBS Lett. 498, 223-227.
27. Oheda, M., Hase, S., Ono, M. and Ikenaka, T. (1988) Structures of the sugar chains of recombinant human granulocyte-colony-stimulating factor produced by Chinese hamster ovary cells. J. Biochem. 103, 544-546.
28. Clogston, C. L., Hu, S., Boone, T. C. and Lu, H. S. (1993) Glycosidase digestion, electrophoresis and chromatographic analysis of recombinant human granulocyte colony-stimulating factor glycoforms produced in Chinese hamster ovary cells. J. Chromatogr. 637, 55-62.
29. Tamada, T., Honjo, E., Maeda, Y., Okamoto, T., Ishibashi, M., Tokunaga, M. and Kuroki, R. (2006) Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex. Proc. Natl. Acad. Sci. U.S.A. 103, 3135-3140.
30. Okazaki, T., Ebihara, S., Asada, M., Yamanda, S., Saijo, Y., Shiraishi, Y., Ebihara, T., Niu, K., Mei, H., Arai, H. and Yambe, T. (2007) Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes. Am. J. Pathol. 171, 1093-1103.
31. Pacher, P. and Szabo, C. (2007) Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc. Drug. Rev. 25, 235-260.
32. Ungvari, Z., Gupte, S. A., Recchia, F. A., Batkai, S. and Pacher, P. (2005) Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr. Vasc. Pharmacol. 3, 221-229.
33. Pacher, P., Liaudet, L., Bai, P., Virag, L., Mabley, J. G., Hasko, G. and Szabo, C. (2002) Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J. Pharmacol. Exp. Ther. 300, 862-867.